Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.

BACK TO LIST

Patient
Name:	Emanuelli, Rodolfo
DOB:	17-JUN-1984 (Age: 41)
Gender:	male
Address:	Contrada Adelmo, 20 Piano 5 31027 Spresiano (Italy)
ID:	7624-273065-3 (ECI)

Report
Date:	23-FEB-2020

Laboratory
dr Ample, Ex Laboratoire Central Européenne Boulevard du Jardin Botanique 32 1000 Brussels (Belgium)

Requested by
Centro di Medicina Viale della Repubblica 10b 31020 Villorba (Italy)

Specimen
Collected:	23-FEB-2020

Hematology

Test	23-FEB-2020	Reference Range	Unit
Leukocytes [#/volume] in Blood by Automated count	7.1	4.0 - 11.0	10*3/uL
Erythrocytes [#/volume] in Blood by Automated count	5.1	4.5 - 5.9	10*6/uL
Hemoglobin [Mass/volume] in Blood	12.2 L	13.5 - 17.5	g/dL
Hematocrit [Volume Fraction] of Blood by Automated count	35.4 L	39 - 50	%
MCV [Entitic mean volume] in Red Blood Cells by Automated count	90.6	80 - 100	fL
MCH [Entitic mass] by Automated count	31.9	27 - 33	pg
MCHC [Entitic Mass/volume] in Red Blood Cells by Automated count	34.0	32.0 - 36.0	g/dL
Erythrocyte distribution width [Entitic volume] by Automated count	43.6	36 - 48	fL
Platelets [#/volume] in Blood by Automated count	207.5	150 - 450	10*3/uL
Platelet distribution width [Entitic volume] in Blood by Automated count	345.8 H	9.4 - 12.3	fL
Platelet [Entitic mean volume] in Blood by Automated count	9.6	7.2 - 11.2	fL

Chemistry

Test	23-FEB-2020	Reference Range	Unit
Hemoglobin A1c/Hemoglobin.total in Blood	5.4	4.8 - 5.9	%
Glucose [Mass/volume] in Blood	180.8 H	70 - 100	mg/dL
Urea nitrogen [Mass/volume] in Blood	10.6	7 - 20	mg/dL
Creatinine [Mass/volume] in Blood	1.4 H	0.6 - 1.2	mg/dL
Calcium [Mass/volume] in Blood	8.6	8.5 - 10.5	mg/dL
Sodium [Moles/volume] in Blood	137.7	135 - 145	mmol/L
Potassium [Moles/volume] in Blood	4.8	3.5 - 5.0	mmol/L
Chloride [Moles/volume] in Blood	110.6 H	98 - 107	mmol/L
Carbon dioxide, total [Moles/volume] in Blood	26.6	22 - 29	mmol/L
Cholesterol [Mass/volume] in Serum or Plasma	258.5 H	125 - 200	mg/dL
Triglyceride [Mass/volume] in Serum or Plasma	254.9 H	0 - 150	mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay	172.8 H	0 - 100	mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma	34.8 L	40 - 60	mg/dL
Microalbumin/Creatinine [Mass Ratio] in Urine	10.3	0 - 30	mg/g

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows significant hyperglycemia with normal HbA1c, suggesting possible acute glucose elevation. Renal function is mildly impaired (elevated creatinine), and there is dyslipidemia (high total cholesterol, LDL, triglycerides, low HDL). Mild anemia is present (low hemoglobin, hematocrit). Elevated chloride and platelet distribution width are noted. Recommend further evaluation for diabetes, cardiovascular risk, and renal function; clinical correlation advised.

Conclusion and Recommendations based on this report and previous findings known to us

The patient shows significant hyperglycemia with normal HbA1c, suggesting possible acute glucose elevation. Renal function is mildly impaired (elevated creatinine), and there is dyslipidemia (high total cholesterol, LDL, triglycerides, low HDL). Mild anemia is present (low hemoglobin, hematocrit). Elevated chloride and platelet distribution width are noted. Recommend further evaluation for diabetes, cardiovascular risk, and renal function; clinical correlation advised.